PCE: Pharmacotherapy Management of COPD Exacerbation
Rate 1: dispensed systemic corticosteroid within 14 days. Rate 2: dispensed bronchodilator within 30 days.
Measure description
Rate 1: dispensed systemic corticosteroid within 14 days. Rate 2: dispensed bronchodilator within 30 days.
Eligible population
COPD members with exacerbation event
Performance drivers
GOLD-aligned management.
Documentation & PA strategy
Document AECOPD exacerbation + systemic steroid + bronchodilator at discharge.
Why HEDIS matters for prior authorization
Health plans align prior authorization criteria with HEDIS measures: documenting your patient meets the HEDIS definition often streamlines or eliminates PA hurdles. For Medicare Advantage in particular, plans are heavily incentivized via Star Ratings to push members and providers toward measure compliance, which translates into faster approvals for measure-aligned services.
Frequently asked questions
What does HEDIS measure PCE measure?
Rate 1: dispensed systemic corticosteroid within 14 days. Rate 2: dispensed bronchodilator within 30 days.
What drives performance on this measure?
GOLD-aligned management.
How should clinicians document for this measure?
Document AECOPD exacerbation + systemic steroid + bronchodilator at discharge.
What is the eligible population?
COPD members with exacerbation event
Streamline PCE workflow with ApprovalHelp
ApprovalHelp automates clinical PA, appeals, and HEDIS-aligned documentation. no setup fee.
Get started →Contact: hello@approvalhelp.com